BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9352746)

  • 1. Natural killer cell frequency and serum cytokine levels in monoclonal gammopathies: correlation of bone marrow granular lymphocytes to prognosis.
    Sawanobori M; Suzuki K; Nakagawa Y; Inoue Y; Utsuyama M; Hirokawa K
    Acta Haematol; 1997; 98(3):150-4. PubMed ID: 9352746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cell frequency and function in patients with monoclonal gammopathies.
    Famularo G; D'Ambrosio A; Quintieri F; Di Giovanni S; Parzanese I; Pizzuto F; Giacomelli R; Pugliese O; Tonietti G
    J Clin Lab Immunol; 1992; 37(3):99-109. PubMed ID: 1285130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cell activity in monoclonal gammopathies: relation to disease activity.
    Osterborg A; Nilsson B; Björkholm M; Holm G; Mellstedt H
    Eur J Haematol; 1990 Sep; 45(3):153-7. PubMed ID: 1699786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunoregulatory cells in patients with monoclonal gammopathies].
    Kuriyama Y; Kawanishi Y; Iwase O; Nakano M; Toyama K
    Rinsho Ketsueki; 1994 Jul; 35(7):642-8. PubMed ID: 7914943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vbeta repertoire.
    Pérez-Andres M; Almeida J; Martin-Ayuso M; Moro MJ; Martin-Nuñez G; Galende J; Hernandez J; Mateo G; San Miguel JF; Orfao A; ;
    Cancer; 2006 Mar; 106(6):1296-305. PubMed ID: 16475149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
    Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B and T lymphocytic populations and subpopulations and natural killer cells (NK) in blood of patients with myeloma and with monoclonal gammopathy of undetermined significance (MGUS).
    Büchi G; Girotto M; Termine G; Gario S; Grosso E; Autino R; Zappalà C
    Pathologica; 1985; 77(1050):385-93. PubMed ID: 3879633
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphocyte profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: flow-cytometric characterization and analysis in a two-dimensional correlation biplot.
    Van den Hove LE; Meeus P; Derom A; Demuynck H; Verhoef GE; Vandenberghe P; Boogaerts MA
    Ann Hematol; 1998 Jun; 76(6):249-56. PubMed ID: 9692812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High serum interleukin-2 levels in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma.
    Cimino G; Avvisati G; Amadori S; Di Gregorio AO; Magliocca V; Petrucci MT; Sgadari C
    Nouv Rev Fr Hematol (1978); 1989; 31(5):329-32. PubMed ID: 2587201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral blood lymphocyte subsets in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Tienhaara A; Pelliniemi TT
    Clin Lab Haematol; 1994 Sep; 16(3):213-23. PubMed ID: 7828409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive markers of bone turnover and plasma cytokines differ in osteoporotic patients with multiple myeloma and monoclonal gammopathies of undetermined significance.
    Diamond T; Levy S; Smith A; Day P; Manoharan A
    Intern Med J; 2001 Jul; 31(5):272-8. PubMed ID: 11512598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of shared idiotypes by paraproteins from patients with multiple myeloma and monoclonal gammopathy of undetermined significance.
    Berenson JR; Lichtenstein A; Hart S; Palomares D; Miller RA
    Blood; 1990 Jun; 75(11):2107-11. PubMed ID: 1693294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in the suppressor-inducer T cell subset in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Shapira R; Froom P; Kinarty A; Aghai E; Lahat N
    Br J Haematol; 1989 Feb; 71(2):223-5. PubMed ID: 2522313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in activatory and inhibitory natural killer (NK) receptors may induce progression to multiple myeloma: implications for tumor evasion of T and NK cells.
    Bernal M; Garrido P; Jiménez P; Carretero R; Almagro M; López P; Navarro P; Garrido F; Ruiz-Cabello F
    Hum Immunol; 2009 Oct; 70(10):854-7. PubMed ID: 19580833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Ki67 positive lymphocytes in multiple myeloma and benign monoclonal gammopathy.
    Miguel-Garcia A; Matutes E; Tarin F; Garcia-Talavera J; Miguel-Sosa A; Carbonell F; Catovsky D
    J Clin Pathol; 1995 Sep; 48(9):835-9. PubMed ID: 7490317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenetic relation between monoclonal gammopathies of undetermined significance and multiple myeloma.
    Greipp PR; Lust JA
    Stem Cells; 1995 Aug; 13 Suppl 2():10-21. PubMed ID: 8520496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
    Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
    Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating monoclonal B lymphocytes in multiple myeloma.
    Chiu EK; Ganeshaguru K; Hoffbrand AV; Mehta AB
    Br J Haematol; 1989 May; 72(1):28-31. PubMed ID: 2786732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential pattern of CD4+ and CD8+ T-cell immunity to MAGE-A1/A2/A3 in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma.
    Goodyear OC; Pratt G; McLarnon A; Cook M; Piper K; Moss P
    Blood; 2008 Oct; 112(8):3362-72. PubMed ID: 18658027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of serum IL-6 level in monoclonal gammopathies.
    DuVillard L; Guiguet M; Casasnovas RO; Caillot D; Monnier-Zeller V; Bernard A; Guy H; Solary E
    Br J Haematol; 1995 Feb; 89(2):243-9. PubMed ID: 7873373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.